The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases

Recent clinical guidelines have emphasized the importance of screening for cognitive impairment in older adults with diabetes, however, there is still a lack of understanding about the drug therapy. Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are widely used in the treatment of type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Dihe, Yang, Shuo, Zhao, Xue, Wang, Guixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943601/
https://www.ncbi.nlm.nih.gov/pubmed/35340338
http://dx.doi.org/10.2147/DDDT.S348055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943601/
https://www.ncbi.nlm.nih.gov/pubmed/35340338
http://dx.doi.org/10.2147/DDDT.S348055

Ejemplares similares